Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification

12 Apr 2024

Abstract excerpt

BACKGROUND: Glioma, a highly invasive and deadly form of human neoplasm, presents a pressing need for the exploration of potential therapeutic targets. While the lysosomal protein transmembrane 4A (LATPM4A) has been identified as a risk factor in pancreatic cancer patients, its role in glioma remains unexplored. METHODS: The analysis of differentially expressed genes (DEG) was conducted from The Cancer Genome...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to Genomics and Chromatin Dynamics
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38613802
DOI: 10.18632/aging.205736

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verificationPMID 38613802Read ↗

A cuproptosis-related gene DLAT as a novel prognostic marker and its relevance to immune infiltration in low-grade gliomasSemantic proximity Read ↗

Multi-omics analysis reveals AFAP1L1 as a prognostic biomarker and immune-related therapeutic target in glioma.Semantic proximity Read ↗

Pan‑cancer Analysis of LAP2α as a Potential Prognostic and Immunological Biomarker for Multiple Cancer Types Including GliomaSemantic proximity Read ↗

Pan-Cancer Analysis of TASL: A Novel Immune Infiltration-Related Biomarker for Tumor Prognosis and Immunotherapy Response PredictionSemantic proximity Read ↗

Prognostic and Therapeutic Value of LSM5 Gene in Human Brain Cancer Glioma: An Omics Database Exploration ApproachSemantic proximity Read ↗

Cuproptosis-related gene DLAT is a prognostic and immunological biomarker in pan-cancerSemantic proximity Read ↗

CMTM6 overexpression is associated with molecular and clinical characteristics of malignancy and predicts poor prognosis in gliomasSemantic proximity Read ↗

Mining multi-omics data for molecular subtyping in gliomas facilitates precise clinical treatmentSemantic proximity Read ↗

Systematic comprehension of genomics and mutational landscape of glioma: A goal towards advanced therapeutics.Semantic proximity Read ↗

Integrated single-cell and bulk RNA-sequencing data reveal prognosis and therapeutic response in low-grade glioma based on hypoxia-lactylation related genesSemantic proximity Read ↗

Bioinformatics analysis of LMAN1 expression, clinical characteristics, and its effects on cell proliferation and invasion in gliomaSemantic proximity Read ↗

Prognostic value and drug sensitivity of FBXL6 in gliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.